Opportunities for Drug Shortage Prevention – Industry and Regulator Views

Complimentary 
Learning Level: Intermediate
Time: 1100 - 1230 ET
Session Length: 1.5 hours

The pressure points of the COVID-19 pandemic challenged us to broaden our thinking and change our practices. Adjustments have been made at a global scale and more people are immersed in the experience of dealing with a crisis than ever before. This has generated a spotlight on pharmaceutical supply chain practices. Patients and regulators have been increasingly asking: what are best practices for business continuity planning to prevent drug shortages? what do companies do to prepare for these events to ensure continued supply?

As the pandemic has evolved, the introduction and supply of therapies and vaccines for COVID-19 are not the only products that require careful attention. It has been and continues to be critical to ensure uninterrupted supply for all essential drug products that address serious medical conditions and support emergency healthcare. This webinar has been developed in response to the increasing interest in how best to ensure continuous pharmaceutical supply. Industry and regulatory experts will reflect on the current state of drug shortage prevention and share thoughts on how we may do better.

Learning Objectives

  1. Provide the audience with a better understanding of the key opportunities to advance drug shortage prevention, particularly in the areas of business continuity planning and health authority engagement.
  2. Hear and explore current thinking on drug shortage prevention from global health authority regulators
  3. Share information on key resources available for improving drug shortage prevention and inspire companies to pursue improvements.

Register


Speakers

Nasir Egal
Vice President, Global Quality
Sanofi
Diane L. Hustead
Director, Regulatory Affairs
Merck & Co., Inc.
Valerie E. Jensen, CAPT (Ret.), RPh
Associate Director, Drug Shortage Staff
CDER/FDA
Mélanie Cachet
Deputy Director of the Inspection Division
ANSM
Lisa Hedman
Senior Advisor
WHO Division of Access To Medicines and Health Products (MHP)

Receive Webinar Notifications

Stay up-to-date on registration, webinar opportunities, and more by signing up to receive notifications.

Name
Company Type